Recombinant Haptoglobin HP Beta Chain Expression System
Summary
The European Patent Office published patent application EP4334342A1 for CSL Behring AG and Universität Zürich covering an expression system for producing recombinant haptoglobin (HP) beta chain. The patent was published March 25, 2026, with inventors including Rebecca Butcher, Catherine Owcuzarek, Thomas Gentinetta, Dominik Schaer, and Michael Hugelshofer. This is a routine patent publication with no compliance obligations.
What changed
EPO published patent application EP4334342A1, a biotechnology patent covering an expression system for producing recombinant haptoglobin (HP) beta chain. The applicants are CSL Behring AG and Universität Zürich. Designated states cover all current EPO member states including Germany, France, UK, Italy, Spain, and others.
This patent publication does not impose any compliance deadlines or regulatory obligations on pharmaceutical companies or other entities. It represents intellectual property protection for a recombinant protein expression technology with potential therapeutic applications. No immediate action is required from compliance teams.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
EXPRESSION SYSTEM FOR PRODUCING A RECOMBINANT HAPTOGLOBIN (HP) BETA CHAIN
Publication EP4334342A1 Kind: A1 Mar 25, 2026
Applicants
CSL Behring AG, Universität Zürich
Inventors
BUTCHER, Rebecca, OWCZAREK, Catherine, GENTINETTA, Thomas, SCHAER, Dominik, HUGELSHOFER, Michael
IPC Classifications
C07K 14/805 20060101AFI20221111BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for ChangeBridge: EPO Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.